Get alerts
Special noticeFederal buyer

Area of Interest under PHO ISO: ASCENT-IBO

Verified 1 h agoUpdated Oct 7 · Amendment
Responses dueThu, Oct 155:00 PM ET · District of Columbia time7 days left
PostedWed, Aug 51 amendment, last Oct 7
Solicitation no.ARPA-H-SN-26-158SAM.gov
Set-asideNoneOpen to all firms

What the agency is buying

by RFPFinder from the notice and attachments; the solicitation governs

The Department of Health and Human Services is seeking proposals for the Accelerating Safe Clinical Evaluation of Novel Treatments: Ibogaine for Better outcomes in OUD (ASCENT-IBO) project. The contract will be awarded based on the Proposers Day event.

Scope

  • Accelerating Safe Clinical Evaluation of Novel Treatments: Ibogaine for Better outcomes in OUD (ASCENT-IBO)
  • Proposers Day event
Days to respond: 7

How to get the bid documents

  1. Download the 1 stored document below; 3 more open at the source
  2. Check the submission requirements in the compliance checklist
  3. Submit as the notice directs before 5:00 PM ET on Oct 15
Documents · 4 items, 4 files
  • PDF
    SN_26_158_ASCENT_IBO.pdf130 KB · 6 pages
  • DOC
    ARPA-H-SN-26-156: Implementation of Executive Order 14401 Accelerating Medical Treatments for Serious Mental Illnessexternal link
  • DOC
    PHO ISO (ARPA-H-SOL-24-106)external link
  • DOC
    Submit a Question to the PHO Teamexternal link
Open the original listing on SAM.gov

Details

Place of performance
Washington, District of Columbia
Buyer type
Federal
Notice type
Special Notice
Solicitation no.
ARPA-H-SN-26-158
NAICS
NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)): 107 open RFPs
PSC
PSC AN13: 10 open RFPs
Local presence
Not required
Amendments
1, last Oct 7
Contact
SEE DESCRIPTION SECTION
Office
NATIONAL INSTITUTES OF HEALTH · ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Email
do_NOT_use_THIS_email_ADDRESS@arpa-h.gov

Not stated in the notice: estimated value, contract type, period of performance. Check the bid documents.

Contact details from the source notice. Contact the buyer only about this solicitation.

Key dates

Wed, Aug 5Posted
Not statedQuestions due
Thu, Oct 15 · 5:00 PM ETResponses due · 7 days left Under 14 days
Amendment 1
Wed, Oct 7 · This special notice builds upon a previous notice and includes additional details, including a Proposers Day event.

Change log

verified Fri, Oct 9 · 12:30 AM ET
  1. Posted · Special NoticeWed, Aug 5 · 9:01 AM ET
  2. Amendment · This special notice builds upon a previous notice and includes additional details, including a Proposers Day event.Wed, Oct 7 · 12:33 AM ET

Change log starts Oct 5, 2026 (tracking began); earlier amendments at SAM.gov are being pulled in.

Report a problem

Notice as published

Area of Interest under PHO ISO: ASCENT-IBO

See attached Special Notice ARPA-H-SN-26-158: Accelerating Safe Clinical Evaluation of Novel Treatments: Ibogaine for Better outcomes in OUD (ASCENT-IBO) This Special Notice builds upon ARPA-H-SN-26-156 and includes details related to a Proposers Day event.

Similar National Institutes of Health awards · PSC AN13

USAspending.gov, last 36 months

10 awards matched · tier 2: National Institutes of Health + PSC AN13; nothing from this office. Most recent:

  • Sep 15, 2024CURIA GLOBAL INCFLORIO BPN PROJECT BPN-3693875N95024F00001 · DELIVERY ORDER · National Institutes of Health · ends Sep 15, 2030$1.1M
Pro

Pro shows every award with the recipient, amount, period and a link to the award record, plus a CSV export. $39/mo.

Sign in or upgrade

Awards updated Fri, Oct 9, 2026 · 12:03 AM ET.

This contracting office

10 other open notices from this office · buys mostly Other

Similar open RFPs

same PSC AN13

Listing collected from SAM.gov. Always confirm requirements in the original solicitation before you bid.

Alert meView on SAM.gov